Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Aug;33(8):2124–2130. doi: 10.1128/jcm.33.8.2124-2130.1995

Quantitative PCR for human herpesviruses 6 and 7.

P Secchiero 1, D Zella 1, R W Crowley 1, R C Gallo 1, P Lusso 1
PMCID: PMC228347  PMID: 7559960

Abstract

A quantitative PCR assay for the detection of human herpesvirus 6 (HHV-6) (variants A and B) and HHV-7 DNAs in clinical samples was developed. The assay uses a nonhomologous internal standard (IS) for each virus that is coamplified with the wild-type target sequence in the same vial and with the same pair of primers. This method allows for a correction of the variability of efficiency of the PCR technique. A standard curve is constructed for each experiment by coamplification of known quantities of the cloned HHV-6 or HHV-7 target templates with the respective IS. Absolute quantitation of the test samples is then achieved by determining the viral target/IS ratio of the hybridization signals of the amplification products and plotting this value against the standard curve. Using this assay, we quantitated the amount of HHV-6 or HHV-7 DNA in infected cell cultures and demonstrated an inhibitory effect of phosphonoformic acid on the replication of HHV-6 and HHV-7 in vitro. As the first clinical application of this procedure, we performed preliminary measurements of the loads of HHV-6 and HHV-7 in lymph nodes from patients with Hodgkin's disease and AIDS. Application of this quantitative PCR method should be helpful for elucidating the pathogenic roles of HHV-6 and HHV-7.

Full Text

The Full Text of this article is available as a PDF (413.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker-André M., Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res. 1989 Nov 25;17(22):9437–9446. doi: 10.1093/nar/17.22.9437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berneman Z. N., Ablashi D. V., Li G., Eger-Fletcher M., Reitz M. S., Jr, Hung C. L., Brus I., Komaroff A. L., Gallo R. C. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10552–10556. doi: 10.1073/pnas.89.21.10552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Briggs M., Fox J., Tedder R. S. Age prevalence of antibody to human herpesvirus 6. Lancet. 1988 May 7;1(8593):1058–1059. doi: 10.1016/s0140-6736(88)91883-1. [DOI] [PubMed] [Google Scholar]
  4. Carrigan D. R., Drobyski W. R., Russler S. K., Tapper M. A., Knox K. K., Ash R. C. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet. 1991 Jul 20;338(8760):147–149. doi: 10.1016/0140-6736(91)90137-e. [DOI] [PubMed] [Google Scholar]
  5. Clark D. A., Freeland M. L., Mackie L. K., Jarrett R. F., Onions D. E. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis. 1993 Jul;168(1):251–252. doi: 10.1093/infdis/168.1.251. [DOI] [PubMed] [Google Scholar]
  6. Cone R. W., Hackman R. C., Huang M. L., Bowden R. A., Meyers J. D., Metcalf M., Zeh J., Ashley R., Corey L. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med. 1993 Jul 15;329(3):156–161. doi: 10.1056/NEJM199307153290302. [DOI] [PubMed] [Google Scholar]
  7. Cone R. W., Huang M. L., Ashley R., Corey L. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol. 1993 May;31(5):1262–1267. doi: 10.1128/jcm.31.5.1262-1267.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Di Luca D., Katsafanas G., Schirmer E. C., Balachandran N., Frenkel N. The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology. 1990 Mar;175(1):199–210. doi: 10.1016/0042-6822(90)90200-b. [DOI] [PubMed] [Google Scholar]
  9. Drobyski W. R., Dunne W. M., Burd E. M., Knox K. K., Ash R. C., Horowitz M. M., Flomenberg N., Carrigan D. R. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis. 1993 Mar;167(3):735–739. doi: 10.1093/infdis/167.3.735. [DOI] [PubMed] [Google Scholar]
  10. Drobyski W. R., Knox K. K., Majewski D., Carrigan D. R. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med. 1994 May 12;330(19):1356–1360. doi: 10.1056/NEJM199405123301905. [DOI] [PubMed] [Google Scholar]
  11. Fairfax M. R., Schacker T., Cone R. W., Collier A. C., Corey L. Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts. J Infect Dis. 1994 Jun;169(6):1342–1345. doi: 10.1093/infdis/169.6.1342. [DOI] [PubMed] [Google Scholar]
  12. Fox J. D., Ward P., Briggs M., Irving W., Stammers T. G., Tedder R. S. Production of IgM antibody to HHV6 in reactivation and primary infection. Epidemiol Infect. 1990 Apr;104(2):289–296. doi: 10.1017/s095026880005946x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frenkel N., Schirmer E. C., Wyatt L. S., Katsafanas G., Roffman E., Danovich R. M., June C. H. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci U S A. 1990 Jan;87(2):748–752. doi: 10.1073/pnas.87.2.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gerna G., Baldanti F., Sarasini A., Furione M., Percivalle E., Revello M. G., Zipeto D., Zella D. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group. Antimicrob Agents Chemother. 1994 Jan;38(1):38–44. doi: 10.1128/aac.38.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gilliland G., Perrin S., Blanchard K., Bunn H. F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2725–2729. doi: 10.1073/pnas.87.7.2725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harlow S. P., Stewart C. C. Quantitation of c-myc gene amplification by a competitive PCR assay system. PCR Methods Appl. 1993 Dec;3(3):163–168. doi: 10.1101/gr.3.3.163. [DOI] [PubMed] [Google Scholar]
  17. Holodniy M., Katzenstein D. A., Israelski D. M., Merigan T. C. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J Clin Invest. 1991 Nov;88(5):1755–1759. doi: 10.1172/JCI115494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jalava T., Lehtovaara P., Kallio A., Ranki M., Söderlund H. Quantification of hepatitis B virus DNA by competitive amplification and hybridization on microplates. Biotechniques. 1993 Jul;15(1):134–139. [PubMed] [Google Scholar]
  19. Kellogg D. E., Sninsky J. J., Kwok S. Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction. Anal Biochem. 1990 Sep;189(2):202–208. doi: 10.1016/0003-2697(90)90108-l. [DOI] [PubMed] [Google Scholar]
  20. Knox K. K., Carrigan D. R. Disseminated active HHV-6 infections in patients with AIDS. Lancet. 1994 Mar 5;343(8897):577–578. doi: 10.1016/s0140-6736(94)91524-5. [DOI] [PubMed] [Google Scholar]
  21. Lawyer F. C., Stoffel S., Saiki R. K., Chang S. Y., Landre P. A., Abramson R. D., Gelfand D. H. High-level expression, purification, and enzymatic characterization of full-length Thermus aquaticus DNA polymerase and a truncated form deficient in 5' to 3' exonuclease activity. PCR Methods Appl. 1993 May;2(4):275–287. doi: 10.1101/gr.2.4.275. [DOI] [PubMed] [Google Scholar]
  22. Linz U. Thermocycler temperature variation invalidates PCR results. Biotechniques. 1990 Sep;9(3):286, 288, 290-3. [PubMed] [Google Scholar]
  23. Littler E., Lawrence G., Liu M. Y., Barrell B. G., Arrand J. R. Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J Virol. 1990 Feb;64(2):714–722. doi: 10.1128/jvi.64.2.714-722.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lusso P., Gallo R. C. Human herpesvirus 6 in AIDS. Lancet. 1994 Mar 5;343(8897):555–556. doi: 10.1016/s0140-6736(94)91515-6. [DOI] [PubMed] [Google Scholar]
  25. Lusso P., Gallo R. C. Human herpesvirus 6. Baillieres Clin Haematol. 1995 Mar;8(1):201–223. doi: 10.1016/s0950-3536(05)80238-0. [DOI] [PubMed] [Google Scholar]
  26. Lusso P., Markham P. D., Tschachler E., di Marzo Veronese F., Salahuddin S. Z., Ablashi D. V., Pahwa S., Krohn K., Gallo R. C. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med. 1988 May 1;167(5):1659–1670. doi: 10.1084/jem.167.5.1659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lusso P., Secchiero P., Crowley R. W., Garzino-Demo A., Berneman Z. N., Gallo R. C. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3872–3876. doi: 10.1073/pnas.91.9.3872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Menzo S., Bagnarelli P., Giacca M., Manzin A., Varaldo P. E., Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol. 1992 Jul;30(7):1752–1757. doi: 10.1128/jcm.30.7.1752-1757.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Noonan K. E., Beck C., Holzmayer T. A., Chin J. E., Wunder J. S., Andrulis I. L., Gazdar A. F., Willman C. L., Griffith B., Von Hoff D. D. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7160–7164. doi: 10.1073/pnas.87.18.7160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ochert A. S., Boulter A. W., Birnbaum W., Johnson N. W., Teo C. G. Inhibitory effect of salivary fluids on PCR: potency and removal. PCR Methods Appl. 1994 Jun;3(6):365–368. doi: 10.1101/gr.3.6.365. [DOI] [PubMed] [Google Scholar]
  31. Okuno T., Takahashi K., Balachandra K., Shiraki K., Yamanishi K., Takahashi M., Baba K. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol. 1989 Apr;27(4):651–653. doi: 10.1128/jcm.27.4.651-653.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. doi: 10.1126/science.8096089. [DOI] [PubMed] [Google Scholar]
  33. Poli F., Cattaneo R., Crespiatico L., Nocco A., Sirchia G. A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing. PCR Methods Appl. 1993 May;2(4):356–358. doi: 10.1101/gr.2.4.356. [DOI] [PubMed] [Google Scholar]
  34. Pruksananonda P., Hall C. B., Insel R. A., McIntyre K., Pellett P. E., Long C. E., Schnabel K. C., Pincus P. H., Stamey F. R., Dambaugh T. R. Primary human herpesvirus 6 infection in young children. N Engl J Med. 1992 May 28;326(22):1445–1450. doi: 10.1056/NEJM199205283262201. [DOI] [PubMed] [Google Scholar]
  35. Salahuddin S. Z., Ablashi D. V., Markham P. D., Josephs S. F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986 Oct 31;234(4776):596–601. doi: 10.1126/science.2876520. [DOI] [PubMed] [Google Scholar]
  36. Saxinger C., Polesky H., Eby N., Grufferman S., Murphy R., Tegtmeir G., Parekh V., Memon S., Hung C. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods. 1988 Sep;21(1-4):199–208. doi: 10.1016/0166-0934(88)90066-3. [DOI] [PubMed] [Google Scholar]
  37. Secchiero P., Berneman Z. N., Gallo R. C., Lusso P. Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. Virology. 1994 Jul;202(1):506–512. doi: 10.1006/viro.1994.1371. [DOI] [PubMed] [Google Scholar]
  38. Secchiero P., Carrigan D. R., Asano Y., Benedetti L., Crowley R. W., Komaroff A. L., Gallo R. C., Lusso P. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis. 1995 Feb;171(2):273–280. doi: 10.1093/infdis/171.2.273. [DOI] [PubMed] [Google Scholar]
  39. Streicher H. Z., Hung C. L., Ablashi D. V., Hellman K., Saxinger C., Fullen J., Salahuddin S. Z. In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods. 1988 Sep;21(1-4):301–304. doi: 10.1016/0166-0934(88)90075-4. [DOI] [PubMed] [Google Scholar]
  40. Wyatt L. S., Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol. 1992 May;66(5):3206–3209. doi: 10.1128/jvi.66.5.3206-3209.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988 May 14;1(8594):1065–1067. doi: 10.1016/s0140-6736(88)91893-4. [DOI] [PubMed] [Google Scholar]
  42. Zipeto D., Baldanti F., Zella D., Furione M., Cavicchini A., Milanesi G., Gerna G. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. J Virol Methods. 1993 Sep;44(1):45–55. doi: 10.1016/0166-0934(93)90006-d. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES